Skip to main content

Advertisement

Log in

Expander/Implant Removal After Breast Reconstruction: Analysis of Risk Factors and Timeline

  • Original Article
  • Breast Surgery
  • Published:
Aesthetic Plastic Surgery Aims and scope Submit manuscript

Abstract

Introduction

Removal of tissue expanders (TE) or implants is a dire consequence of breast reconstruction, and has the potential to halt the reconstructive efforts. Our goals were to characterize a cohort of patients with TE/implant removal, to perform a time-based analysis, and to review the bacteriology associated with explanted devices.

Materials and Methods

Review of a prospectively maintained database was performed to identify patients who underwent TE/implant removal. Patient characteristics, surgical technique, adjuvant therapies, indications, complications, culture results were obtained. Data were analyzed according to timing of explantation.

Results

A total of 55 TE and implants were removed in 43 patients. Reasons for explantation were infection (58%), patient request (22%), and wound-related complications (20%). The majority of explantations occurred after 30 days (62%), and after Stage I (81%). Median days to explantation was 62. Patients of older age (p = 0.01) and higher BMI (p = 0.02) were more likely to undergo explantation after Stage I. The most commonly cultured organisms were S. epidermidis (10.9%), S. aureus (10.9%) and P. aeruginosa (10.9%). Antibiotic resistance was commonly encountered for ampicillin, cefazolin, penicillin, and erythromycin.

Conclusion

Infection is the most common reason for explantation after prosthetic breast reconstruction. Patients should be carefully monitored for a prolonged period of time after Stage I, as the majority of explantations occur in this stage but beyond 30 days. For oral treatment, fluoroquinolones and trimethoprim–sulfamethoxazole and for IV treatment a combination of vancomycin or daptomycin with piperacillin–tazobactam or imipenems/carbapenems appear to be appropriate choices according to our culture results.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. American Society of Plastic Surgeons Procedural Statistics. https://d2wirczt3b6wjm.cloudfront.net/News/Statistics/2015/plastic-surgery-statistics-full-report-2015.pdf. Accessed 9 Mar 2017

  2. Disa JJ, Ad-El DD, Cohen SM et al (1999) The premature removal of tissue expanders in breast reconstruction. Plast Reconstr Surg 104(6):1662–1665

    Article  CAS  PubMed  Google Scholar 

  3. Spear SL, Majidian A (1998) Immediate breast reconstruction in two stages using textured, integrated-valve tissue expanders and breast implants: a retrospective review of 171 consecutive breast reconstructions from 1989 to 1996. Plast Reconstr Surg 101(1):53–63

    Article  CAS  PubMed  Google Scholar 

  4. Cohen JB, Carroll C, Tenenbaum MM et al (2015) Breast implant-associated infections: the role of the national surgical quality improvement program and the local microbiome. Plast Reconstr Surg 136(5):921–929

    Article  CAS  PubMed  Google Scholar 

  5. Cordeiro PG, McCarthy CM (2006) A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: part I. A prospective analysis of early complications. Plast Reconstr Surg 118(4):825–831

    Article  CAS  PubMed  Google Scholar 

  6. Dolen UC, Schmidt AC, Um GT et al (2016) Impact of neoadjuvant and adjuvant chemotherapy on immediate tissue expander breast reconstruction. Ann Surg Onc 23(7):2357–2366

    Article  Google Scholar 

  7. Francis SH, Ruberg RL, Stevenson KB et al (2009) Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg 124(6):1790–1796

    Article  CAS  PubMed  Google Scholar 

  8. Khansa I, Hendrick RG, Shore A et al (2014) Breast reconstruction with tissue expanders: implementation of a standardized best-practices protocol to reduce infection rates. Plast Reconstr Surg 134(1):11–18

    Article  CAS  PubMed  Google Scholar 

  9. McCarthy CM, Mehrara BJ, Riedel E et al (2008) Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121(6):1886–1892

    Article  CAS  PubMed  Google Scholar 

  10. Viola GM, Baumann DP, Mohan K et al (2016) Improving antimicrobial regimens for the treatment of breast tissue expander-related infections. Plast Reconstr Surg Global Open 4(5):e704–e704

    Article  Google Scholar 

  11. Weichman KE, Levine SM, Wilson SC et al (2013) Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction. Ann Plast Surg 71(2):140–143

    Article  CAS  PubMed  Google Scholar 

  12. Luce EA, Pierce CE (2015) Lack of validity of the American college of surgeons national surgical quality improvement program database for alloplastic immediate postmastectomy reconstruction. Plast Reconstr Surg 136(3):296e–300e

    Article  CAS  PubMed  Google Scholar 

  13. Fischer JP, Nelson JA, Serletti JM et al (2013) Peri-operative risk factors associated with early tissue expander (TE) loss following immediate breast reconstruction (IBR): a review of 9305 patients from the 2005–2010 ACS-NSQIP datasets. J Plast Reconstr Aesthet Surg 66(11):1504–1512

    Article  PubMed  Google Scholar 

  14. Fischer JP, Wes AM, Tuggle CT et al (2013) Risk analysis of early implant loss after immediate breast reconstruction: a review of 14,585 patients. J Am Coll Surg 217(6):983–990

    Article  PubMed  Google Scholar 

  15. Franchelli S, Pesce M, Savaia S et al (2015) Clinical and microbiological characterization of late breast implant infections after reconstructive breast cancer surgery. Surg Infect 16(5):636–644

    Article  Google Scholar 

  16. Alderman A, Gutowski K, Ahuja A et al (2014) Postmastectomy expander implant breast reconstruction guideline work G. ASPS clinical practice guideline summary on breast reconstruction with expanders and implants. Plast Reconstr Surg 134(4):648e–655e

    Article  CAS  PubMed  Google Scholar 

  17. Avraham T, Weichman KE, Wilson S et al (2015) Postoperative expansion is not a primary cause of infection in immediate breast reconstruction with tissue expanders. Breast J 21(5):501–507

    Article  PubMed  Google Scholar 

  18. Berry T, Brooks S, Sydow N et al (2010) Complication rates of radiation on tissue expander and autologous tissue breast reconstruction. Ann Surg Oncol 17(Suppl 3):202–210

    Article  PubMed  Google Scholar 

  19. Hanwright PJ, Davila AA, Hirsch EM et al (2013) The differential effect of BMI on prosthetic versus autogenous breast reconstruction: a multivariate analysis of 12,986 patients. Breast 22(5):938–945

    Article  PubMed  Google Scholar 

  20. Hirsch EM, Seth AK, Kim JYS et al (2014) Analysis of risk factors for complications in expander/implant breast reconstruction by stage of reconstruction. Plast Reconstr Surg 134(5):692e–699e

    Article  CAS  PubMed  Google Scholar 

  21. Wang F, Koltz PF, Sbitany H (2014) Lessons learned from the American college of surgeons national surgical quality improvement program database: has centralized data collection improved immediate breast reconstruction outcomes and safety? Plast Reconstr Surg 134(5):859–868

    Article  CAS  PubMed  Google Scholar 

  22. Xue DQ, Qian C, Yang L et al (2012) Risk factors for surgical site infections after breast surgery: a systematic review and meta-analysis. Eur J Surg Oncol 38(5):375–381

    Article  CAS  PubMed  Google Scholar 

  23. Woo K-J, Paik JM, Mun G-H et al (2016) Risk factors for complications in immediate expander-implant breast reconstruction for non-obese patients: impact of breast size on complications. Aesthet Plast Surg 40(1):71–78

    Article  Google Scholar 

  24. Achermann Y, Goldstein EJC, Coenye T et al (2014) Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev 27(3):419–440

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Khuri SF, Daley J, Henderson W et al (1998) The department of Veterans Affairs’ NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA surgical quality improvement program. Ann Surg 228(4):491–507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kim JYS, Khavanin N, Jordan SW et al (2014) Individualized risk of surgical-site infection: an application of the breast reconstruction risk assessment score. Plast Reconstr Surg 134(3):351e–362e

    Article  PubMed  Google Scholar 

  27. Silva AK, Lapin B, Yao KA et al (2015) The effect of contralateral prophylactic mastectomy on perioperative complications in women undergoing immediate breast reconstruction: a NSQIP analysis. Ann Surg Onc 22(11):3474–3480

    Article  Google Scholar 

  28. Ogunleye AA, de Blacam C, Curtis MS et al (2012) An analysis of delayed breast reconstruction outcomes as recorded in the American College of surgeons national surgical quality improvement program. J Plast Reconstr Aesthet Surg 65(3):289–294

    Article  PubMed  Google Scholar 

  29. Leyngold MM, Stutman RL, Khiabani KT et al (2012) Contributing variables to post mastectomy tissue expander infection. Breast J 18(4):351–356

    Article  PubMed  Google Scholar 

  30. McCullough MC, Chu CK, Duggal CS et al (2016) Antibiotic prophylaxis and resistance in surgical site infection after immediate tissue expander reconstruction of the breast. Ann Plast Surg 77(5):501–505

    Article  CAS  PubMed  Google Scholar 

  31. Reish RG, Damjanovic B, Austen JWG et al (2013) Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success. Plast Reconstr Surg 131(6):1223–1230

    Article  CAS  PubMed  Google Scholar 

  32. Spear SL, Seruya M (2010) Management of the infected or exposed breast prosthesis: a single surgeon’s 15-year experience with 69 patients. Plast Reconstr Surg 125(4):1074–1084

    Article  CAS  PubMed  Google Scholar 

  33. Spear SL, Howard MA, Boehmler JH et al (2004) The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg 113(6):1634–1644

    Article  PubMed  Google Scholar 

  34. Prince MD, Suber JS, Aya-Ay ML et al (2012) Prosthesis salvage in breast reconstruction patients with periprosthetic infection and exposure. Plast Reconstr Surg 129(1):42–48

    Article  CAS  PubMed  Google Scholar 

  35. Chun JK, Schulman MR (2007) The infected breast prosthesis after mastectomy reconstruction: successful salvage of nine implants in eight consecutive patients. Plast Reconstr Surg 120(3):581–589

    Article  CAS  PubMed  Google Scholar 

  36. Yii N-W, Khoo CTK (2003) Salvage of infected expander prostheses in breast reconstruction. Plast Reconstr Surg 111(3):1087–1092

    Article  PubMed  Google Scholar 

  37. Meybodi F, Sedaghat N, French J et al (2015) Implant salvage in breast reconstruction with severe peri-prosthetic infection. ANZ J Surg. Nov 17:epub ahead of print

  38. Ariyan S, Martin J, Lal A et al (2015) Antibiotic prophylaxis for preventing surgical-site infection in plastic surgery: an evidence-based consensus conference statement from the American association of plastic surgeons. Plast Reconstr Surg 135(6):1723–1739

    Article  CAS  PubMed  Google Scholar 

  39. Nahabedian MY, Tsangaris T, Momen B et al (2003) Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 112(2):467–476

    Article  PubMed  Google Scholar 

  40. Baschnagel AM, Shah C, Wilkinson JB et al (2012) Failure rate and cosmesis of immediate tissue expander/implant breast reconstruction after postmastectomy irradiation. Clin Breast Cancer 12(6):428–432

    Article  PubMed  Google Scholar 

  41. Cordeiro PG, Pusic AL, Disa JJ et al (2004) Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg 113(3):877–881

    Article  PubMed  Google Scholar 

  42. Cordeiro PG, Albornoz CR, McCormick B et al (2015) What is the optimum timing of postmastectomy radiotherapy in two-stage prosthetic reconstruction: radiation to the tissue expander or permanent implant? Plast Reconstr Surg 135(6):1509–1517

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Tallet AV, Salem N, Moutardier V et al (2003) Radiotherapy and immediate two-stage breast reconstruction with a tissue expander and implant: complications and esthetic results. Int J Radiat Oncol Biol Phys 57(1):136–142

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cemile Nurdan Ozturk.

Ethics declarations

Conflict of interest

The authors have no disclosures.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ozturk, C.N., Ozturk, C., Soucise, A. et al. Expander/Implant Removal After Breast Reconstruction: Analysis of Risk Factors and Timeline. Aesth Plast Surg 42, 64–72 (2018). https://doi.org/10.1007/s00266-017-1031-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00266-017-1031-8

Keywords

Navigation